The interaction between insulin signaling and AD or cognitive impairment can be also demonstrated by research data showing improvements in the cognitive function of AD patients after the administration of antidiabetic drugs such as intranasal insulin, metformin, thiazolidinediones, and incretins. This evidence concerns the gene INS and Alzheimer disease.